<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Suchada Phimsen และผู้แต่งคนอื่นๆ. (2025) Secretory leukocyte protease inhibitor (SLPI) as a diagnostic biomarker and facilitator of cell proliferation in cholangiocarcinoma. &lt;i&gt;Journal of Basic and Applied Pharmacology&lt;/i&gt;, &lt;i&gt;5&lt;/i&gt;(2), O73-82.</APA><Chicago>Suchada Phimsen และผู้แต่งคนอื่นๆ. "Secretory leukocyte protease inhibitor (SLPI) as a diagnostic biomarker and facilitator of cell proliferation in cholangiocarcinoma". Journal of Basic and Applied Pharmacology  5 (2025):O73-82.</Chicago><MLA>Suchada Phimsen และผู้แต่งคนอื่นๆ. Secretory leukocyte protease inhibitor (SLPI) as a diagnostic biomarker and facilitator of cell proliferation in cholangiocarcinoma. The Pharmacological and Therapeutic Society of Thailand:ม.ป.ท. 2025.</MLA></bibliography></xml>
